查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球动物授精市场-2022-2029
市场调查报告书
商品编码
1129269

全球动物授精市场-2022-2029

Global Veterinary Artificial Insemination Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

预计动物人工授精应用的技术进步将推动市场增长。

佛罗里达大学创建了面向市场的乳製品 (MOD) 饲料配方工具 (RAFT) 移动应用程序。该软件有 iOS 和 Android 版本，将根据该国的需求量身定制，然后供卢旺达农民使用，为他们的奶牛创造均衡的饮食。第 2 章提出了农民在人工授精或自然交配后确定奶牛妊娠状态的解决方案。未怀孕的奶牛可以通过早期诊断技术尽快重新开始配种或人工授精。有了这项技术，奶农可以确保每头奶牛每年生一头小牛，提高繁殖效率。这种效果还可以确保奶牛在其一生中生产更多的牛奶，这有利于奶农。由于这些原因，预计市场在预测期内将扩大。

约束

与动物育种相关的风险，例如疾病和传染病的流行、合格兽医短缺、高成本以及限制原材料进口的严格政府法规，将在预测期内阻碍市场。因素

行业分析

动物人工授精市场根据供应链分析、价格分析等各种行业因素对市场进行深入分析。

COVID-19 影响分析

COVID-19 大流行对医疗保健系统和市场产生了适度影响。大流行扰乱了畜禽供应链，减少了对动物食品销售的需求。动物因饮食和兽医护理不足而遭受痛苦，包括需要及时进行人工授精、妊娠试验和驱虫。例如，2020 年 6 月，畜牧业部启动了一项计划，为家禽养殖户和业主提供电话援助，以保护农民和工人免受 COVID-19 的侵害。此外，在 COVID-19 大流行期间，人工授精被送到农民家门口。因此，这些活动导致市场扩张。

另一方面，由于对牛奶和乳製品 (MMP) 的需求显着下降，COVID-19 停工对牛奶生产商和加工商产生了负面影响。结果，MMP 的价格下跌，大大增加了其利益相关者的损失。牛奶生产商每天的经济损失估计为 112.3 亿日元，其中超过四分之一发生在北方邦和拉贾斯坦邦这两个州。这些损失主要集中在九个州。降低价格带来的消费者福利改善不足以完全补偿生产者，造成每天 66.7 亿日元的经济损失无法挽回。因此，预计封锁将产生长期阴影，并取决于随后的宽鬆措施，影响牛奶生产和乳製品行业的盈利能力。如上所述，市场受到影响，但随着经济活动的恢復，预计将迅速恢復。

全球动物授精市场报告将提供对大约 45 多个市场数据表、40 多个数字和 180 页的访问。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因子
    • 驱动程序
      • 预计动物人工授精应用的技术进步将推动市场增长。
    • 限制因素
      • 动物人工授精的高成本预计将阻碍市场增长。
    • 机会
    • 影响分析

第五章行业分析

  • 供应链分析
  • 定价分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按动物类型

  • 牛
  • 猪
  • 绵羊/山羊
  • 马
  • 其他

第 8 章按产品类型

  • 正常精液
  • 性交精液

第九章技术

  • 宫腔管腹膜人工授精
  • 宫颈人工授精
  • 宫腔内人工授精
  • 输卵管内人工授精

第 10 章，最终用户

  • 兽医医院
  • 兽医诊所
  • 动物育种
  • 其他

第 11 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 12 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 产品基准
  • 值得关注的重点公司列表

第 13 章公司简介

  • IMV Technologies
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Neogen Corporation
  • Bovine ELite LLC
  • Agtech Inc.
  • Zoetis Inc.
  • Jorgensen Labs
  • Revival Animal Health
  • Merck Animal Health
  • Swine Genetics International
  • Santa Cruz Biotechnology

第 14 章全球动物授精市场-DataM

简介目录
Product Code: DMVH5841

Market Overview

Veterinary Artificial Insemination Market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

Artificial insemination involves creating a pregnancy without engaging in sexual activity by injecting sperm or semen into the female uterus or cervix. By using fresh, uncooked, or frozen semen straw, it is possible to breed cattle. In vivo fertilization uses artificial insemination to make an animal pregnant. Because it works better during the animal's heat cycle, this technique is also employed in sperm donation and reproductive technology, allowing animals to reproduce on schedule. Enhancing the genetics and reproduction of animals using veterinary artificial insemination is a unique biotechnology approach.

Market Dynamics

Technological advancement in veterinary artificial insemination applications is expected to drive market growth.

The University of Florida created the Market Oriented Dairy (MOD) Ration Formulation Tool (RAFT) mobile application. Before being used by farmers in Rwanda to build a balanced ration for their dairy cattle, the software, which is available in iOS and Android versions, will be tailored for the country's needs. After artificial insemination or natural mating, a solution to help farmers determine the pregnant state of cattle is proposed in the second section. A non-pregnant cow can resume mating or artificial insemination as soon as feasible with the early diagnostic technique. With this technique, farmers can ensure that each of their cows produces a calf yearly, achieving breeding efficiency. Moreover, this effectiveness will guarantee that cows produce more milk throughout their lives and benefit farmers. Thus, from the above statements, the market is expected to boost in the forecast period.

Restraint

Risks related to animal breeding, including the spread of disease and infection, a lack of qualified veterinarians, the high cost of this procedure, and stringent government regulations restricting the import of raw materials are some factors the market is expected to get hampered in the forecast period.

Industry Analysis

The veterinary artificial insemination market provides in-depth analysis of the market based on various industry factors such as supply chain analysis, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. The pandemic has disrupted the supply chains for livestock and poultry, reducing the demand for the sale of animal food. Due to inadequate diet and veterinary treatment, including the requirement for timely artificial insemination, pregnancy checks, and deworming, animals suffered. For instance, the Animal Husbandry Department of India started a program in June 2020 that provided telephonic help to poultry farmers and owners to protect farmers and workers against COVID-19. Moreover, during the COVID-19 pandemic, artificial insemination was supplied to farmers' doorsteps. As a result, these activities have helped the market expand.

In contrast, the COVID-19 lockout has had a negative effect on milk producers and processors since there has been a considerable decrease in demand for milk and milk products (MMP). The resulting drop in MMP's pricing has greatly contributed to their stakeholders' losses. Preliminary estimates of economic losses to milk producers stand at 112.3 crores per day, with more than one-fourth of these losses coming from only two states, Uttar Pradesh and Rajasthan. These losses are heavily concentrated in nine states. The increase in consumer welfare brought on by price decreases is insufficient to fully compensate the producers, leaving 66.7 crores in daily economic losses unrecovered. Therefore, lockdown is predicted to cast a lengthy shadow, affecting milk output and the dairy industry's profitability depending on the subsequent mitigating measures taken. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Segment Analysis

Sexed Semen segment is expected to hold the largest market share in veterinary artificial insemination market

The sexed semen segment is expected to dominate in 2021. The segment benefits from the yields of various breeds, taking into account genetic modification, crossbreeding, and research on the development of certain breeds from sexed semen. According to the evidence, using both normal bovine semen for terminal crosses and sexed semen for purebreds increases meat production in dairy herds. Pregnancy rates in cattle receiving 2 million sexed sperm per insemination dose are almost 80% of those in cattle receiving conventional semen at standard sperm doses.

Nevertheless, since the growth of dairy heifers is essential for the dairy industry and advancements in sexing processes have boosted fertility, approximately 2 million bovine semen applied annually in the United States are sexed. Overall, the data show that, compared to artificial insemination with conventional semen, artificial insemination with sexed semen tends to improve the financial gain of dairy farmers. Additionally, according to the cost-benefit analysis, sexed semen can help the dairy herd expand more quickly and profitably by boosting the number of heifer deliveries. For instance, Sexcel was created using a cutting-edge, patented method for sexing bovine semen, utilizing ABS's best genetics. With this cutting-edge technology, the cells are not subjected to the tremendous pressures, electric currents, and shear forces required to make the sexed semen that farmers can access. Sexcel Sexed Genetics is available for Holstein, Jersey, and Norwegian Red. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global veterinary artificial insemination market

In 2021, North America accounted for the highest revenue share. The increased adoption of artificial insemination procedures in cattle, rising milk consumption and production of beef, growing awareness regarding artificial insemination, expansion and acquisitions by the key market players in the region are some factors the market is expected to boost in the forecast period. For instance, in the U.S., artificial insemination was used in breeding 80% of dairy animals. With over 90% of the market share in North America, the U.S. will be one of the major markets for artificial animal insemination (A.I.) procedures due to their greater adoption rate. Moreover, Semex and Nedap announced the growth of their productive relationship in January 2022. More nations now offer the Semex ai24 program with Nedap technology, allowing dairy farmers to enhance their herds' productivity and performance greatly. Additionally, In April 2021, Elanco Animal Health cooperated with Ducks Unlimited to support agriculture and environmental sustainability, particularly for beef cattle production across North America. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the veterinary artificial insemination market are IMV Technologies, Neogen Corporation, Bovine ELite LLC, Agtech Inc., Zoetis Inc., Jorgensen Labs, Revival Animal Health, Merck Animal Health, Swine Genetics International, Santa Cruz Biotechnology.

Zoetis Inc.:

Overview:

Zoetis is a global animal health company focusing on livestock and companion animals. It is involved in discovering, developing, producing, and marketing animal health drugs, vaccines, and diagnostic tools. Biodevices, genetic diagnostics, and precision livestock farming supplement its goods. The business, among other things, sells vaccines, parasiticides, anti-infective treatments, and medicated feed additives. Its client supply services (CSS) organization also provides contract manufacturing services to other parties. The company has manufacturing sites worldwide. It sells goods through direct marketing channels and distributors in the Americas, Europe, Africa, Asia, and Australia to veterinarians, livestock producers, and people who raise and care for farm and companion animals.

Product Portfolio:

LUTALYSE: The most widely used and approved prostaglandin on the market is LUTALYSE Injection (dinoprost tromethamine injection), which veterinarians recommend. Program for synchronizing artificial insemination with LUTALYSE can increase breeding success. Today, producers and veterinarians have more alternatives than ever for employing LUTALYSE in reproduction programs. Now that FACTREL Injection (gonadorelin injection) has received approval, it can also be used in conjunction with LUTALYSE to synchronize estrous cycles and enable fixed-time artificial insemination (FTAI) in dairy cows that are nursing.

The global veterinary artificial insemination market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological advancement in veterinary artificial insemination applications is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The high cost of veterinary artificial insemination is expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Animal Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal Type
    • 7.1.2. Market Attractiveness Index, By Animal Type Segment
  • 7.2. Cattle*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Swine
  • 7.4. Ovine & Caprine
  • 7.5. Equine
  • 7.6. Others

8. By Product Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 8.1.2. Market Attractiveness Index, By Product Type Segment
  • 8.2. Normal Semen*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Sexed Semen

9. By Technique

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 9.1.2. Market Attractiveness Index, By Technique Segment
  • 9.2. Intrauterine Tub peritoneal Insemination*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Intracervical Insemination
  • 9.4. Intrauterine Insemination
  • 9.5. Intratubal Insemination

10. By End user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.1.2. Market Attractiveness Index, By End user Segment
  • 10.2. Veterinary Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Veterinary Clinics
  • 10.4. Animal Husbandry
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. IMV Technologies*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Neogen Corporation
  • 13.3. Bovine ELite LLC
  • 13.4. Agtech Inc.
  • 13.5. Zoetis Inc.
  • 13.6. Jorgensen Labs
  • 13.7. Revival Animal Health
  • 13.8. Merck Animal Health
  • 13.9. Swine Genetics International
  • 13.10. Santa Cruz Biotechnology

LIST NOT EXHAUSTIVE

14. Global Veterinary Artificial Insemination Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us